[Nuclear medicine pain therapy in osseous metastases of prostate cancer].
In patients with advanced prostate cancer, adequate palliation of pain from skeletal metastases is of primary importance. Radionuclide therapy offers an effective treatment with few side effects or risks after the primary therapeutic modalities, i.e. androgen deprivation, chemotherapy, and percutaneous radiation therapy, are exhausted. This review discusses the potential and limitations of radionuclide therapy and provides recommendations for patient selection and practical implementation of radionuclide therapy.
Müller
S
S
Kliniken und Polikliniken für Nuklearmedizin, Universitätsklinikum Essen.
Rembrink
K
K
Reiners
C
C
D001853:Bone Marrow / Q000528:radiation effects; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D006801:Humans; D008297:Male; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology; D011879:Radiotherapy Dosage